Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.21
Delayed Data
As of Oct 20
 -0.38 / -0.47%
Today’s Change
63.76
Today|||52-Week Range
86.27
+13.41%
Year-to-Date

Today’s Trading

Previous close81.59
Today’s open81.95
Day’s range80.45 - 81.95
Volume9,188,325
Average volume (3 months)9,520,406
Market cap$106.1B
Dividend yield2.56%
Data as of 4:14pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)-6.45%
Revenue growth (last year)-5.37%
P/E ratio8.8
Price/Sales3.21
Price/Book5.63

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.16-0.63%
BIIBBiogen-4.32-1.26%
ILMNIllumina Inc+4.70+2.29%
----
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$2.13
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts